Trinity Biotech plc [TRIB]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 33.51% | 33.51% | 5.60% |
| Loss % | -24.19% | -24.19% | 0.00% |
| Duration | 21.0d | 17d | 9.6d |
| Total Pivots Found | 4 |
| Gain/Loss Legs | 3 (2 Gain / 1 Loss) |
| Last Pivot | Top @ $0.73 on 2026-06-02 |
| Change since Last Pivot | $-0.08 (-11.21%) |
Next Pivot Prediction Last: $0.65
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $0.56 |
| Predicted Price (Median) | $0.56 |
| Predicted Price Range (~68%) | $0.56 - $0.56 |
| Change to Avg Target | $-0.09 (-14.61%) |
| Predicted Date (Avg) | 2026-06-23 |
| Predicted Date Range (~68%) | 2026-06-13 - 2026-07-02 |
| Basis | Based on 1 historical losses (Avg: -24.19%, Median: -24.19%, StdDev of Abs: 0.00%) and duration (Avg: 21.0 days, StdDev: 9.6 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Trinity Biotech plc declines -3.70%.
Trinity Biotech plc (TRIB) stock price faced a major setback on Friday after the stock fell $-0.0250 (-3.70%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. With 86 560 shares traded, volume yesterday reached $56 264. This was 88 340 shares less than the prior day. Compared to the 10-day average of 136 313 shares, volume was less than the average.
Trinity Biotech plc signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-30%), medium- (-30%), and long-term (-30%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Trinity Biotech plc Support & Resistance Levels
The stock is trading above the closest support level at $0.610. approximately $0.0400 (6.15%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s10.61 -
Trinity Biotech plc Evaluation
- Short score: -3.27
- Medium score: -3.09
- Long score: -4.31